The engineering of protein nanoparticles represents an exciting frontier in biotechnology and nanomedicine, with applications ranging from next-generation vaccines to targeted drug delivery systems. However, the computational design of these structures —especially those with high symmetries, such as icosahedra— encounters a fundamental obstacle: GPU memory. Generative models that work with all atoms represent each pair of tokens and atoms quadratically, which means that as the number of chains and residues increases, the memory of a single GPU quickly becomes saturated.
To overcome this limitation, context parallelism strategies have emerged that distribute quadratic activations across a mesh of multiple GPUs without modifying the model's pre-trained weights. This approach, known as Design-CP, implements two variants: one-dimensional row-wise sharding and two-dimensional grid sharding with ring attention. Both allow scaling the maximum asymmetric subunit size following a square root trend relative to the number of GPUs, with the 2D version offering better execution time. It is especially relevant that, thanks to the strong symmetry constraints of point groups, these techniques can be directly applied to the end-to-end design of icosahedral nanoparticles, obtaining favorable structural and interface metrics in silico. The design of octahedral nanoparticles has even been demonstrated on small GPU clusters with only 16 GB, opening the door to a democratization of the design of large protein assemblies.
In this context, having robust and adaptable technological solutions is key for laboratories and companies to take advantage of these advances. At Q2BSTUDIO we develop custom applications that integrate complex computational workflows, from the orchestration of generative models to deployment on cloud infrastructures. For example, we offer artificial intelligence for businesses that allows implementing AI agents capable of managing protein design pipelines, monitoring metrics, and adjusting parameters in real time. Additionally, our AWS and Azure cloud services facilitate scaling these processes to hundreds of GPUs without worrying about infrastructure management.
Cybersecurity is another fundamental pillar when handling sensitive research data, and at Q2BSTUDIO we provide specialized services in pentesting and cloud environment protection. We also help organizations transform the data generated in computational experiments into valuable business information through business intelligence and Power BI services, enabling visualization of correlations between design parameters and experimental results. All of this is supported by a custom software approach, where each solution is tailored to the specific needs of the client, whether an academic group or a pharmaceutical company.
The combination of advanced algorithms like Design-CP with flexible and scalable development platforms accelerates the translation of research into real-world applications. At Q2BSTUDIO we are committed to providing the technological layer that makes this synergy possible, helping our clients design the nanoparticles of tomorrow with the power of artificial intelligence and the robustness of software engineering.

.jpg)



